跳至主要内容
临床试验/NCT02816944
NCT02816944Unknown1 期

Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
80
试验地点
1
主要终点
80 patients of refractory neoplasms with EUS-guided laser ablation-related effectivity as assessed by MRI

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of endoscopic ultrasonography (EUS) guided laser ablation liver, pancreas, and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with refractory neoplasms including small hepatocellular carcinoma adjacent to the gastrointestinal tract, pancreatic neuroendocrine tumor, retroperitoneal tumor with less than 3 cm in diameter;
  • Patients with Child-Pugh A/B;
  • Patients with PLT ≥ 50*10E9/L and PT ≤ 20s.

排除标准

  • Patients with severe cardiopulmonary disease, intolerant endoscopy and anesthesia, upper gastrointestinal bleeding in shock, corrosive esophagitis and acute gastritis.

结局指标

主要结局

80 patients of refractory neoplasms with EUS-guided laser ablation-related effectivity as assessed by MRI

时间窗: up to 24 months

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验